Man in the laboratory
Products
Introducing MosaiQ™ by Quotient
Discover now

Latest updates

News
Quotient Limited Announces CE Mark Approval for Initial Serological Disease Screening Microarray

JERSEY, Channel Islands, Feb.

Quotient Limited to Report Third Quarter 2020 Financial Results and Host Conference Call
News
Quotient Limited to Report Third Quarter 2020 Financial Results and Host Conference Call

JERSEY, Channel Islands, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2019, will be released before market open on Thursday, January 30, 2020.

Quotient aims to reduce the time to receive blood test results
News
Quotient Aims to Reduce Blood Testing Time

C’est une revolution dans l’univers de l’analyse de sang. Quotient, une société basée à Eysins (VD), aux portes de Nyon, met sur le marché une nouvelle technique qui permet d’obtenir des résultats complets d’un échantillon avec une grande rapidité.

CNN
News
CEO Franz Walt on CNN Money Switzerland

Swiss company taps into U.S. appetite for risk

Image
News
Quotient at AABB 2019

Quotient is attending the 2019 AABB Annual Meeting in San Antonio, TX, from 19-22 October 2019.

View all
Who we are
The future made possible. Reshaping in−vitro diagnostics.
Building on 30 years of experience in transfusion diagnostics, we deliver game changing diagnostic solutions, empowering our customers to realize their full potential and improve their business.
Learn more
Investors
4:00 PM EDT • Feb 19, 2020
QTNT
7.31USD
+1.39%
Quotient Limited Announces CE Mark Approval for Initial Serological Disease Screening Microarray
Read More
Quotient Limited Provides an Update on Recent MosaiQ Milestone Achievements together with Third Quarter Fiscal 2020 Results
Read More
Quotient Limited to Report Third Quarter 2020 Financial Results and Host Conference Call
Read More
Read all press releases
Careers
Careers
Help us achieve our mission in transforming transfusion diagnostics.
Joining Quotient is an opportunity to become part of a team which will shape the future of the company.
Learn more

Available positions

Job title
Department
Location
Senior R&D Engineer
MosaiQ-Assay Development
Dublin, Ireland
Maintenance & Calibration Technician
Facility
Eysins, Switzerland
Quality Engineer
Quality Assurance
Edinburgh, United Kingdom
View all jobs
Our reagents by Quotient
Alba by Quotient. Experience. Expertise. Value.
These are just some of the qualities that set us apart from the competition. You can have peace of mind using our products, which have been time-tested for more than 30 years.
Learn more

Latest social posts